Cargando…
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
Strategies to control HIV-1 replication without antiviral therapy are needed to achieve a functional cure. To exploit the innate antiviral function of restriction factor cytidine deaminase APOBEC3G (A3G), we developed self-activating lentiviral vectors that efficiently deliver HIV-1 Vif-resistant mu...
Autores principales: | Delviks-Frankenberry, Krista A., Ackerman, Daniel, Timberlake, Nina D., Hamscher, Maria, Nikolaitchik, Olga A., Hu, Wei-Shau, Torbett, Bruce E., Pathak, Vinay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889484/ https://www.ncbi.nlm.nih.gov/pubmed/31778955 http://dx.doi.org/10.1016/j.omtn.2019.10.024 |
Ejemplares similares
-
Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2023) -
Structural Insights into APOBEC3-Mediated Lentiviral Restriction
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2020) -
Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2016) -
Mechanisms and Factors that Influence High Frequency Retroviral Recombination
por: Delviks-Frankenberry, Krista, et al.
Publicado: (2011) -
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA
por: Maiti, Atanu, et al.
Publicado: (2018)